MGMA recently commented on proposed policy changes to the Medicare Advantage (MA) and Medicare Part D Prescription Drug Programs. The Association applauded a proposal to publish a list of precluded providers rather than proceeding with burdensome new requirements, opposed by MGMA, that eligible professionals enroll in or validly opt out of Medicare by Jan. 1, 2019 to have their Part D drugs and MA services covered by Medicare. The Association also underscored the growing burden imposed by patient records requests from MA plans, which MGMA members report can be several thousand records annually. Read the full letter.